Proteinase-activated receptor 2 (PAR2) decreases apoptosis in colonic epithelial cells

Journal of Biological Chemistry

Volumn 289, Issue 49, 2014, Pages 34366-34377

  Iablokov, Vadim ^a   Hirota, Christina L ^a   Peplowski, Michael A ^a   Ramachandran, Rithwik ^a   Mihara, Koichiro ^a   Hollenberg, Morley D ^a   MacNaughton, Wallace K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL DEATH; CHEMICAL ACTIVATION; DISEASE CONTROL;

ANTI-APOPTOTIC EFFECTS; APOPTOTIC PATHWAYS; G PROTEIN COUPLED RECEPTORS; HEALTHY INDIVIDUALS; INFLAMMATORY BOWEL DISEASE; INTESTINAL EPITHELIAL CELLS; PHOSPHATIDYLSERINE; PROTEINASE-ACTIVATED RECEPTOR;

CELL SIGNALING;

2 FUROYL LIGRLO; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CASPASE 3; CASPASE 8; CASPASE 9; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PEPTIDE SLIGKV; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLSERINE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAD; PROTEIN MCL 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 2 AGONIST; SERINE; SMALL INTERFERING RNA; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 2-FUROYL-LIGRLO-AMIDE; CASPASE; MAP2K1 PROTEIN, HUMAN; MAP2K2 PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OLIGOPEPTIDE; SERYL-LEUCYL-ISOLEUCYL--GLYCYL-LYSYL-VALINE;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL SURVIVAL; COLON MUCOSA; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; GENE SILENCING; HEALING; HT 29 CELL LINE; HUMAN; HUMAN CELL; INFLAMMATORY BOWEL DISEASE; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; CALCIUM SIGNALING; COLON; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CALCIUM SIGNALING; CASPASES; CELL LINE, TUMOR; COLON; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INTERFERON-GAMMA; MAP KINASE KINASE 1; MAP KINASE KINASE 2; OLIGOPEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLSERINES; POLY(ADP-RIBOSE) POLYMERASES; RECEPTOR, PAR-2; RNA, SMALL INTERFERING; TRYPSIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84916917407     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.610485     Document Type: Article

References (63)

1. Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., and Kaplan, G. G. (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54.e42; quiz e30
2. Kaser, A., Zeissig, S., and Blumberg, R. S. (2010) Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621
3. Grossmann, J., Walther, K., Artinger, M., Rümmele, P., Woenckhaus, M., and Schölmerich, J. (2002) Induction of apoptosis before shedding of human intestinal epithelial cells. Am. J. Gastroenterol. 97, 1421-1428
4. Zeissig, S., Bojarski, C., Buergel, N., Mankertz, J., Zeitz, M., Fromm, M., and Schulzke, J. D. (2004) Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor α antibody treatment. Gut 53, 1295-1302
5. Dirisina, R., Katzman, R. B., Goretsky, T., Managlia, E., Mittal, N., Williams, D. B., Qiu, W., Yu, J., Chandel, N. S., Zhang, L., and Barrett, T. A. (2011) p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis. Gastroenterology 141, 1036-1045
6. Gitter, A. H., Wullstein, F., Fromm, M., and Schulzke, J. D. (2001) Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 121, 1320-1328
7. Kiesslich, R., Duckworth, C. A., Moussata, D., Gloeckner, A., Lim, L. G., Goetz, M., Pritchard, D. M., Galle, P. R., Neurath, M. F., and Watson, A. J. (2012) Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61, 1146-1153
8. Ossina, N. K., Cannas, A., Powers, V. C., Fitzpatrick, P. A., Knight, J. D., Gilbert, J. R., Shekhtman, E. M., Tomei, L. D., Umansky, S. R., and Kiefer, M. C. (1997) Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272, 16351-16357
9. Procaccino, F., Reinshagen, M., Hoffmann, P., Zeeh, J. M., Lakshmanan, J., McRoberts, J. A., Patel, A., French, S., and Eysselein, V. E. (1994) Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 107, 12-17
10. Sinha, A., Nightingale, J., West, K. P., Berlanga-Acosta, J., and Playford, R. J. (2003) Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N. Engl. J. Med. 349, 350-357
11. Neurath, M. F., and Travis, S. P. (2012) Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 61, 1619-1635
12. Baert, F., Moortgat, L., Van Assche, G., Caenepeel, P., Vergauwe, P., De Vos, M., Stokkers, P., Hommes, D., Rutgeerts, P., Vermeire, S., D'Haens, G., Belgian Inflammatory Bowel Disease Research Group, and North-Holland Gut Club (2010) Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 138, 463-468; quiz e10-1
13. Kong, W., McConalogue, K., Khitin, L. M., Hollenberg, M. D., Payan, D. G., Böhm, S. K., and Bunnett, N. W. (1997) Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc. Natl. Acad. Sci. U.S.A. 94, 8884-8889
14. D'Andrea, M. R., Derian, C. K., Leturcq, D., Baker, S. M., Brunmark, A., Ling, P., Darrow, A. L., Santulli, R. J., Brass, L. F., and Andrade-Gordon, P. (1998) Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J. Histochem. Cytochem. 46, 157-164
15. Adams, M. N., Ramachandran, R., Yau, M. K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., and Hooper, J. D. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol. Ther. 130, 248-282
16. DeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., and Bunnett, N. W. (2000) β-Arrestin-dependent endocytosis of proteinaseactivated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148, 1267-1281
17. Ramachandran, R., Mihara, K., Mathur, M., Rochdi, M. D., Bouvier, M., Defea, K., and Hollenberg, M. D. (2009) Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen- activated protein kinase pathways. Mol. Pharmacol. 76, 791-801
18. Darmoul, D., Gratio, V., Devaud, H., and Laburthe, M. (2004) Proteaseactivated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J. Biol. Chem. 279, 20927-20934
19. Wang, P., Kumar, P., Wang, C., and Defea, K. A. (2007) Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 α and β by protease-activated receptor 2 and β-arrestins. Biochem. J. 408, 221-230
20. Déry, O., Thoma, M. S., Wong, H., Grady, E. F., and Bunnett, N. W. (1999) Trafficking of proteinase-activated receptor-2 and β-arrestin-1 tagged with green fluorescent protein. β-Arrestin-dependent endocytosis of a proteinase receptor. J. Biol. Chem. 274, 18524-18535
21. Hirota, C. L., Moreau, F., Iablokov, V., Dicay, M., Renaux, B., Hollenberg, M. D., and MacNaughton, W. K. (2012) Epidermal growth factor receptor transactivation is required for proteinase-activated receptor-2-induced COX-2 expression in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G111-G119
22. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to Image J: 25 years of image analysis. Nat. Methods 9, 671-675
23. Degasperi, A., Birtwistle, M. R., Volinsky, N., and Rauch, J. (2014) Evaluating strategies to normalise biological replicates of Western blot data. PLoS One 10.1371/journal.pone.0087293
24. Schmittgen, T. D., and Livak, K. J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108
25. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., and Korsmeyer, S. J. (1991) BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 88, 6961-6965
26. Iwamoto, M., Koji, T., Makiyama, K., Kobayashi, N., and Nakane, P. K. (1996) Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol. 180, 152-159
27. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207-2216
28. Frasch, S. C., Henson, P. M., Kailey, J. M., Richter, D. A., Janes, M. S., Fadok, V. A., and Bratton, D. L. (2000) Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cδ. J. Biol. Chem. 275, 23065-23073
29. Adams, M. N., Pagel, C. N., Mackie, E. J., and Hooper, J. D. (2012) Evaluation of antibodies directed against human protease-activated receptor-2. Naunyn Schmiedebergs Arch. Pharmacol. 385, 861-873
30. Duronio, V. (2008) The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem. J. 415, 333-344
31. Anjum, R., and Blenis, J. (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat. Rev. Mol. Cell Biol. 9, 747-758
32. Tait, S. W., and Green, D. R. (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621-632
33. O'Connell, J., Bennett, M. W., Nally, K., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. (2000) Interferon-γ sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis. J. Cell. Physiol. 185, 331-338
34. Gilmore, A. P., Valentijn, A. J., Wang, P., Ranger, A. M., Bundred, N., O'Hare, M. J., Wakeling, A., Korsmeyer, S. J., and Streuli, C. H. (2002) Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. J. Biol. Chem. 277, 27643-27650
35. Quoyer, J., Longuet, C., Broca, C., Linck, N., Costes, S., Varin, E., Bockaert, J., Bertrand, G., and Dalle, S. (2010) GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a β-arrestin 1-mediated ERK1/2 activation in pancreatic β-cells. J. Biol. Chem. 285, 1989-2002
36. Booy, E. P., Henson, E. S., and Gibson, S. B. (2011) Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer. Oncogene 30, 2367-2378
37. Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., and Gores, G. J. (2005) Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology 128, 2054-2065
38. Drake, T. A., Morrissey, J. H., and Edgington, T. S. (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am. J. Pathol. 134, 1087-1097
39. Camerer, E., Huang, W., and Coughlin, S. R. (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. U.S.A. 97, 5255-5260
40. Sorensen, B. B., Rao, L. V., Tornehave, D., Gammeltoft, S., and Petersen, L. C. (2003) Antiapoptotic effect of coagulation factor VIIa. Blood 102, 1708-1715
41. Versteeg, H. H., Spek, C. A., Richel, D. J., and Peppelenbosch, M. P. (2004) Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene 23, 410-417
42. Slee, E. A., Adrain, C., and Martin, S. J. (2001) Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 7320-7326
43. Sawamukai, N., Yukawa, S., Saito, K., Nakayamada, S., Kambayashi, T., and Tanaka, Y. (2010) Mast cell-derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via ρ-mediated signaling. Arthritis Rheum. 62, 952-959
44. Buzza, M. S., Netzel-Arnett, S., Shea-Donohue, T., Zhao, A., Lin, C. Y., List, K., Szabo, R., Fasano, A., Bugge, T. H., and Antalis, T. M. (2010) Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc. Natl. Acad. Sci. U.S.A. 107, 4200-4205
45. Gratio, V., Loriot, C., Virca, G. D., Oikonomopoulou, K., Walker, F., Diamandis, E. P., Hollenberg, M. D., and Darmoul, D. (2011) Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. Am. J. Pathol. 179, 2625-2636
46. Takeuchi, T., Harris, J. L., Huang, W., Yan, K. W., Coughlin, S. R., and Craik, C. S. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342
47. Darragh, M. R., Schneider, E. L., Lou, J., Phojanakong, P. J., Farady, C. J., Marks, J. D., Hann, B. C., and Craik, C. S. (2010) Tumor detection by imaging proteolytic activity. Cancer Res. 70, 1505-1512
48. Ma, Y., Bao-Han, W., Lv, X., Su, Y., Zhao, X., Yin, Y., and Zhang, X. (2013) MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation. PLoS One 8, e72383
49. Cottrell, G. S., Amadesi, S., Grady, E. F., and Bunnett, N. W. (2004) Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J. Biol. Chem. 279, 13532-13539
50. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241
51. Scheid, M. P., Schubert, K. M., and Duronio, V. (1999) Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J. Biol. Chem. 274, 31108-31113
52. Tan, Y., Demeter, M. R., Ruan, H., and Comb, M. J. (2000) BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem. 275, 25865-25869
53. Kim, H., Rafiuddin-Shah, M., Tu, H. C., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J., and Cheng, E. H. (2006) Hierarchical regulation of mitochondrion dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 8, 1348-1358
54. Fang, X., Yu, S., Eder, A., Mao, M., Bast, R. C., Jr., Boyd, D., and Mills, G. B. (1999) Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen- activated protein kinase pathway. Oncogene 18, 6635-6640
55. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X (L). Cell 87, 619-628
56. Wang, J. M., Chao, J. R., Chen, W., Kuo, M. L., Yen, J. J., and Yang-Yen, H. F. (1999) The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell. Biol. 19, 6195-6206
57. Townsend, K. J., Zhou, P., Qian, L., Bieszczad, C. K., Lowrey, C. H., Yen, A., and Craig, R. W. (1999) Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J. Biol. Chem. 274, 1801-1813
58. Domina, A. M., Vrana, J. A., Gregory, M. A., Hann, S. R., and Craig, R. W. (2004) MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene 23, 5301-5315
59. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, J. C. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321
60. Tsuruta, F., Masuyama, N., and Gotoh, Y. (2002) The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277, 14040-14047
61. Gardai, S. J., Hildeman, D. A., Frankel, S. K., Whitlock, B. B., Frasch, S. C., Borregaard, N., Marrack, P., Bratton, D. L., and Henson, P. M. (2004) Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J. Biol. Chem. 279, 21085-21095
62. Ley, R., Balmanno, K., Hadfield, K., Weston, C., and Cook, S. J. (2003) Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278, 18811-18816
63. Luciano, F., Jacquel, A., Colosetti, P., Herrant, M., Cagnol, S., Pages, G., and Auberger, P. (2003) Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22, 6785-6793